Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Absence of Puma and Bim protein leads to autoimmune diseases

Absence of Puma and Bim protein leads to autoimmune diseases

New findings establish connection between microRNAs and cellular metabolism

New findings establish connection between microRNAs and cellular metabolism

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

Arsenic induces acute promyelocytic leukemia remission

Arsenic induces acute promyelocytic leukemia remission

Epizyme commences EPZ-5676 Phase 1 study for MLL-r leukemia

Epizyme commences EPZ-5676 Phase 1 study for MLL-r leukemia

FDA approves Bosulif to treat chronic myelogenous leukemia

FDA approves Bosulif to treat chronic myelogenous leukemia

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

Missing link between bone marrow stem cells and human immune system

Missing link between bone marrow stem cells and human immune system

Weill Cornell Medical College receives three new research grants for translational blood cancer study

Weill Cornell Medical College receives three new research grants for translational blood cancer study

Studies examine how PML gene regulates the fatty acid oxidation pathway

Studies examine how PML gene regulates the fatty acid oxidation pathway

MidCap, EpiCept amend Loan and Security Agreement

MidCap, EpiCept amend Loan and Security Agreement

NCCN announces new guidelines for patients with pancreatic Cancer

NCCN announces new guidelines for patients with pancreatic Cancer

Scientists identify genes that underlie growth of primitive leukemia stem cells

Scientists identify genes that underlie growth of primitive leukemia stem cells

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Research explores impact of radiotherapy in older women with low risk of breast cancer recurrence

Research explores impact of radiotherapy in older women with low risk of breast cancer recurrence

ARIAD initiates multi-center ponatinib Phase 1/2 clinical trial for CML in Japan

ARIAD initiates multi-center ponatinib Phase 1/2 clinical trial for CML in Japan

Researchers use small molecule compound to generate reversible birth control in male mice

Researchers use small molecule compound to generate reversible birth control in male mice

Pediatric imatinib for Philadelphia-chromosome ALL fights relapse

Pediatric imatinib for Philadelphia-chromosome ALL fights relapse

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.